# Aillis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aillis

- Industry: Medical Devices & Equipment
- Headquarters: Tokyo, Japan
- Website: www.aillis.jp
- Total disclosed funding: $9.4M
- Latest round: Series B (Aug 6, 2020)
- Investors on record: 2

## About

Based in Tokyo, Japan, and founded in 2017, Aillis Inc., a.k.a. Aillis operates as a health technology company that focuses on developing an artificial intelligence (AI) technology-related medical device for medical institutions and doctors. The company holds various licenses, including Type I Marketing Authorization for medical devices and licenses for the sales, rentals, and repair of highly controlled medical devices. In April 2025, Aillis Inc. raised JPY 2 billion in venture funding from new investor TAUNS Laboratories, Inc. Aillis, Inc. develops AI-based medical devices focusing on throat examination. The company’s primary product is an AI-equipped pharyngoscopy system that uses a specialized camera to capture detailed pharyngeal images, which are then analyzed by AI to identify conditions such as influenza. The camera, connected to the cloud, allows real-time image synchronization and viewing. Aillis's technology includes proprietary AI and parallel computing systems optimized for fast and secure processing of medical data. The company plans to use the April 2025 funds raised to improve the accuracy of image diagnostics and expand the range of diseases covered by its service.

## Funding rounds

- Series B, Aug 6, 2020, $9.4M — SPARX Group, CEJ Capital

## Investors

- SPARX Group (https://capitalatlas.ai/funds/sparx-group) — Series B
- CEJ Capital (https://capitalatlas.ai/funds/cej-capital) — Series B